ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,602.90
-0.19%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. INVO BioScience Inc (INVO)

  7. INVO BioScience Inc (INVO) News

INVO BioScience (INVO)

INVO BioScience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INVO
DateTimeSourceHeadlineSymbolCompany
21/05/202421:39Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INVOINVO BioScience Inc
15/05/202421:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
15/05/202421:15GlobeNewswire Inc.INVO Reports Record First Quarter 2024 Financial ResultsNASDAQ:INVOINVO BioScience Inc
06/05/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
17/04/202415:25AllPennyStocks.comMicro Cap Massively Bid Up Before Opening BellNASDAQ:INVOINVO BioScience Inc
16/04/202421:59GlobeNewswire Inc.INVO Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:INVOINVO BioScience Inc
06/02/202415:24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVOINVO BioScience Inc
01/02/202414:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
23/01/202413:00GlobeNewswire Inc.NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)NASDAQ:INVOINVO BioScience Inc
17/01/202413:00GlobeNewswire Inc.INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board DirectorsNASDAQ:INVOINVO BioScience Inc
16/01/202422:29Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:INVOINVO BioScience Inc
10/01/202421:46Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:INVOINVO BioScience Inc
10/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
03/01/202422:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
28/12/202322:04Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:INVOINVO BioScience Inc
28/12/202322:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
13/12/202322:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INVOINVO BioScience Inc
13/12/202321:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
11/12/202313:00PR Newswire (US)NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood JournalNASDAQ:INVOINVO BioScience Inc
28/11/202322:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
28/11/202314:00PR Newswire (US)INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity RequirementNASDAQ:INVOINVO BioScience Inc
24/11/202318:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INVOINVO BioScience Inc
20/11/202321:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
13/11/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
13/11/202321:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVOINVO BioScience Inc
13/11/202321:01PR Newswire (US)INVO Reports Record Third Quarter 2023 Financial ResultsNASDAQ:INVOINVO BioScience Inc
13/11/202314:23Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:INVOINVO BioScience Inc
13/11/202314:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
13/11/202314:12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:INVOINVO BioScience Inc
10/11/202314:00PR Newswire (US)NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending MergerNASDAQ:INVOINVO BioScience Inc
 Showing the most relevant articles for your search:NASDAQ:INVO

Your Recent History

NYSE
MAYW
AIM ETF Products
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved